Published in J Nucl Med on May 19, 2010
Prediction of Recurrent Events With 18F-Fluoride (PREFFIR) | NCT02278211
Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography. Nat Commun (2015) 1.27
Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) on PET imaging of atherosclerosis. Eur J Nucl Med Mol Imaging (2015) 0.93
Noninvasive Molecular Imaging of Disease Activity in Atherosclerosis. Circ Res (2016) 0.92
Molecular imaging of atherosclerosis: clinical state-of-the-art. Heart (2013) 0.90
Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see. J Nucl Cardiol (2012) 0.84
Divergent determinants of 18F-NaF uptake and visible calcium deposition in large arteries: relationship with Framingham risk score. Int J Cardiovasc Imaging (2013) 0.82
Molecular imaging of plaque vulnerability. J Nucl Cardiol (2014) 0.81
Positron emission tomography of the vulnerable atherosclerotic plaque in man--a contemporary review. Clin Physiol Funct Imaging (2013) 0.80
Molecular imaging of plaques in coronary arteries with PET and SPECT. J Geriatr Cardiol (2014) 0.79
Thoracic aorta calcification but not inflammation is associated with increased cardiovascular disease risk: results of the CAMONA study. Eur J Nucl Med Mol Imaging (2016) 0.78
Assessing global cardiovascular molecular calcification with 18F-fluoride PET/CT: will this become a clinical reality and a challenge to CT calcification scoring? Eur J Nucl Med Mol Imaging (2012) 0.78
Imaging atherosclerosis with hybrid positron emission tomography/magnetic resonance imaging. Biomed Res Int (2015) 0.78
Future imaging of atherosclerosis: molecular imaging of coronary atherosclerosis with (18)F positron emission tomography. Cardiovasc Diagn Ther (2016) 0.76
Novel Applications of Radionuclide Imaging in Peripheral Vascular Disease. Cardiol Clin (2015) 0.76
F-18 Fluoride Positron Emission Tomography-Computed Tomography for Detecting Atherosclerotic Plaques. Korean J Radiol (2015) 0.76
Biological imaging of atherosclerosis: moving beyond anatomy. J Cardiovasc Transl Res (2013) 0.76
Nuclear Molecular Imaging for Vulnerable Atherosclerotic Plaques. Korean J Radiol (2015) 0.76
PET, CT and MRI characterisation of the atherosclerotic plaque. Eur J Nucl Med Mol Imaging (2010) 0.76
Recent Advances in the Development of PET/SPECT Probes for Atherosclerosis Imaging. Nucl Med Mol Imaging (2016) 0.75
Correlation between thoracic aorta 18F-natrium fluoride uptake and cardiovascular risk. World J Radiol (2016) 0.75
PET Imaging of Atherosclerotic Disease: Advancing Plaque Assessment from Anatomy to Pathophysiology. Curr Atheroscler Rep (2016) 0.75
Recent Advances in Nuclear Cardiology. Nucl Med Mol Imaging (2016) 0.75
Age-related differences in the activity of arterial mineral deposition and regional bone metabolism: a 18F-sodium fluoride positron emission tomography study. Osteoporos Int (2014) 0.75
From inflammation to calcification in atherosclerosis. Eur J Nucl Med Mol Imaging (2017) 0.75
PET imaging of the neurovascular interface in cerebrovascular disease. Nat Rev Neurol (2017) 0.75
Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled study. J Neurol Neurosurg Psychiatry (2012) 1.65
[¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism. Neurology (2012) 1.64
Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours. Eur J Nucl Med Mol Imaging (2011) 1.59
Association of linear ¹⁸F-sodium fluoride accumulation in femoral arteries as a measure of diffuse calcification with cardiovascular risk factors: a PET/CT study. J Nucl Cardiol (2013) 1.50
Intraoperative cone-beam computed tomography in oral and maxillofacial surgery using a C-arm prototype: first clinical experiences after treatment of zygomaticomaxillary complex fractures. J Oral Maxillofac Surg (2009) 1.48
Efficacy and safety levels of preserved and preservative-free tafluprost are equivalent in patients with glaucoma or ocular hypertension: results from a pharmacodynamics analysis. Acta Ophthalmol Suppl (Oxf ) (2008) 1.44
Acute myocardial infarction: evaluation with first-pass enhancement and delayed enhancement MR imaging compared with 201Tl SPECT imaging. Radiology (2004) 1.43
Intraindividual comparison of 123I-mIBG SPECT/MRI, 123I-mIBG SPECT/CT, and MRI for the detection of adrenal pheochromocytoma in patients with elevated urine or plasma catecholamines. Clin Nucl Med (2013) 1.40
Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours. Eur J Nucl Med Mol Imaging (2006) 1.32
Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication. Acta Ophthalmol (2010) 1.29
Extracellular NAD and ATP: Partners in immune cell modulation. Purinergic Signal (2007) 1.26
Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease. J Neurol Neurosurg Psychiatry (2012) 1.17
ADP-ribosylation at R125 gates the P2X7 ion channel by presenting a covalent ligand to its nucleotide binding site. FASEB J (2007) 1.16
Diagnostic value of positron emission tomography combined with computed tomography for evaluating patients with septic shock of unknown origin. J Crit Care (2011) 1.15
Ventral striatal prediction error signaling is associated with dopamine synthesis capacity and fluid intelligence. Hum Brain Mapp (2012) 1.11
NAD+ and ATP released from injured cells induce P2X7-dependent shedding of CD62L and externalization of phosphatidylserine by murine T cells. J Immunol (2009) 1.09
Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: a dual-tracer PET/CT study. J Nucl Med (2011) 1.05
In vivo imaging of mineral deposition in carotid plaque using 18F-sodium fluoride PET/CT: correlation with atherogenic risk factors. J Nucl Med (2011) 1.02
Gene expression patterns and tumor uptake of 18F-FDG, 18F-FLT, and 18F-FEC in PET/MRI of an orthotopic mouse xenotransplantation model of pancreatic cancer. J Nucl Med (2008) 1.01
Combined correction of recovery effect and motion blur for SUV quantification of solitary pulmonary nodules in FDG PET/CT. Eur Radiol (2010) 1.00
Iomazenil-single-photon emission computed tomography reveals selective neuronal loss in magnetic resonance-defined mismatch areas. Stroke (2006) 0.96
Evaluation of intratumoural heterogeneity on ¹⁸F-FDG PET/CT for characterization of peripheral nerve sheath tumours in neurofibromatosis type 1. Eur J Nucl Med Mol Imaging (2012) 0.96
18F-FDG PET/CT for detection and localization of residual or recurrent disease in patients with multiple myeloma after stem cell transplantation. Eur J Nucl Med Mol Imaging (2011) 0.95
Brain and whole-body FDG-PET in diagnosis, treatment monitoring and long-term follow-up of primary CNS lymphoma. Radiol Oncol (2013) 0.91
Association between fully automated MRI-based volumetry of different brain regions and neuropsychological test performance in patients with amnestic mild cognitive impairment and Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci (2012) 0.90
Brain perfusion SPECT in the mouse: normal pattern according to gender and age. Neuroimage (2012) 0.90
ADP-ribosylation of membrane proteins: unveiling the secrets of a crucial regulatory mechanism in mammalian cells. Ann Med (2006) 0.90
Use of genetic immunization to raise antibodies recognizing toxin-related cell surface ADP-ribosyltransferases in native conformation. Cell Immunol (2005) 0.89
Dementia and leukoencephalopathy due to lymphomatosis cerebri. J Neurol Neurosurg Psychiatry (2007) 0.89
Can (18)F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan? Ann Nucl Med (2011) 0.87
The transcription factor Fra-2 promotes mammary tumour progression by changing the adhesive properties of breast cancer cells. Eur J Cancer (2010) 0.86
Improved statistical power of the multilinear reference tissue approach to the quantification of neuroreceptor ligand binding by regularization. J Cereb Blood Flow Metab (2003) 0.86
Development of Alzheimer-disease neuroimaging-biomarkers using mouse models with amyloid-precursor protein-transgene expression. Prog Neurobiol (2011) 0.86
Adhesion of small cell lung cancer cells to E- and P-selectin under physiological flow conditions: implications for metastasis formation. Histochem Cell Biol (2011) 0.86
Feasibility of 11C-acetate PET/CT for imaging of fatty acid synthesis in the atherosclerotic vessel wall. J Nucl Med (2011) 0.86
Cerebral glucose utilisation in hepatitis C virus infection-associated encephalopathy. J Cereb Blood Flow Metab (2011) 0.86
Feasibility of central cannabinoid CB1 receptor imaging with [124I]AM281 PET demonstrated in a schizophrenic patient. Psychiatry Res (2006) 0.85
Comparative diagnostic performance of ¹⁸F-FDG PET/CT versus whole-body MRI for determination of remission status in multiple myeloma after stem cell transplantation. Eur Radiol (2012) 0.85
Accurate determination of metabolic rates from dynamic positron emission tomography data with very-low temporal resolution. J Comput Assist Tomogr (2003) 0.85
In vivo MRI measurement of fetal blood oxygen saturation in cardiac ventricles of fetal sheep: a feasibility study. Magn Reson Med (2010) 0.85
Pulmonary FDG uptake without a CT counterpart - a pitfall in interpreting PET/CT images. Acta Radiol (2011) 0.85
Magnetic resonance imaging of prostate cancer: diffusion-weighted imaging in comparison with sextant biopsy. J Comput Assist Tomogr (2011) 0.84
Hepatobiliary MR contrast agents in hypovascular hepatocellular carcinoma. J Magn Reson Imaging (2014) 0.84
Changes in clinical management and diagnosis following DaTscan SPECT imaging in patients with clinically uncertain parkinsonian syndromes: a 12-week follow-up study. Neurodegener Dis (2012) 0.84
[123I]AM281 single-photon emission computed tomography imaging of central cannabinoid CB1 receptors before and after Delta9-tetrahydrocannabinol therapy and whole-body scanning for assessment of radiation dose in tourette patients. Biol Psychiatry (2004) 0.84
18F-FDG PET/CT for detection of malignant peripheral nerve sheath tumours in neurofibromatosis type 1: tumour-to-liver ratio is superior to an SUVmax cut-off. Eur Radiol (2013) 0.84
18F-FDG-PET/CT in the diagnosis of paraneoplastic neurological syndromes: a retrospective analysis. Eur Radiol (2009) 0.83
Quantification of [18F]-FDG uptake in atherosclerotic plaque: impact of renal function. Ann Nucl Med (2011) 0.83
Identification of transport processes in bioirrigated muddy sediments by [18F]fluoride PET (Positron Emission Tomography). Appl Radiat Isot (2010) 0.83
[18F]FDG and [18F]FLT PET-CT and MR imaging of human neuroblastomas in a SCID mouse xenograft model. Anticancer Res (2008) 0.83
Evaluation of non-uniform weighting in non-linear regression for pharmacokinetic neuroreceptor modelling. Nucl Med Commun (2008) 0.82
Visualisation of neuroblastoma growth in a Scid mouse model using [18F]FDG and [18F]FLT-PET. Anticancer Res (2006) 0.82
Blood-brain barrier permeability for ammonia in patients with different grades of liver fibrosis is not different from healthy controls. J Cereb Blood Flow Metab (2010) 0.82
F-18 FDG PET/CT findings of aggressive NK-cell leukemia. Clin Nucl Med (2011) 0.82
Asphericity of pretherapeutic tumour FDG uptake provides independent prognostic value in head-and-neck cancer. Eur Radiol (2014) 0.81
Radiotracer imaging studies in hepatic encephalopathy: ISHEN practice guidelines. Liver Int (2009) 0.81
Assessment of bone marrow inflammation in patients with myelofibrosis: an 18F-fluorodeoxyglucose PET/CT study. Eur J Nucl Med Mol Imaging (2015) 0.80
Association between FDG uptake, CSF biomarkers and cognitive performance in patients with probable Alzheimer's disease. Eur J Nucl Med Mol Imaging (2009) 0.80
Ecstasy-induced reduction of the availability of the brain serotonin transporter as revealed by [11C](+)McN5652-PET and the multi-linear reference tissue model: loss of transporters or artifact of tracer kinetic modelling? J Psychopharmacol (2006) 0.80
Performance evaluation of stationary and semi-stationary acquisition with a non-stationary small animal multi-pinhole SPECT system. Mol Imaging Biol (2013) 0.80
Abnormal F-18 fluoride uptake in intracranial meningiomas on PET/CT. Clin Nucl Med (2010) 0.80
Voxel-based classification of FDG PET in dementia using inter-scanner normalization. Neuroimage (2013) 0.80
The lectin Helix pomatia agglutinin as a marker of metastases--clinical and experimental studies. Anticancer Res (2005) 0.80
Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer. Int J Radiat Oncol Biol Phys (2010) 0.80
A new formula for rapid assessment of pericardial effusion volume by computed tomography. Acad Radiol (2012) 0.79
Adjusted scaling of FDG positron emission tomography images for statistical evaluation in patients with suspected Alzheimer's disease. J Neuroimaging (2005) 0.79
Objective volumetric comparison of room air versus carbon dioxide for colonic distention at screening CT colonography. Abdom Imaging (2015) 0.79
Glucose uptake in the placenta, fetal brain, heart and liver related to blood flow redistribution during acute hypoxia. J Obstet Gynaecol Res (2011) 0.79
IBZM tool: a fully automated expert system for the evaluation of IBZM SPECT studies. Eur J Nucl Med Mol Imaging (2006) 0.79
Reduced thalamic 18F-flurodeoxyglucose retention in adults with neurofibromatosis type 1. Nucl Med Commun (2008) 0.79
Preservation of left ventricular function and morphology in volume-loaded versus volume-unloaded heterotopic heart transplants. Am J Physiol Heart Circ Physiol (2013) 0.79
Accelerating image acquisition in 64-MDCT: the influence of scan parameters on image resolution and quality in a phantom study. Clin Imaging (2012) 0.79
A hidden giant: Wallenberg syndrome and aortal wall thickening as an atypical presentation of a giant cell arteritis. BMJ Case Rep (2013) 0.78
Chronic alcohol intake abolishes the relationship between dopamine synthesis capacity and learning signals in the ventral striatum. Eur J Neurosci (2014) 0.78
Effects of behavioral therapy or pharmacotherapy on brain glucose metabolism in subjects with obsessive-compulsive disorder as assessed by brain FDG PET. Psychiatry Res (2010) 0.78